Outcome measures for central nervous system symptoms in myotonic dystrophy type 1: insights from a case-controlled study

被引：0
|
作者：
Hamilton, M. J. [1 ,2 ]
McLean, J. [3 ]
Cumming, S. [2 ]
Ballantyne, B. [1 ]
McGhie, J. [2 ]
Jampana, R. [3 ]
Longman, C. [1 ]
Evans, J. J.
Monckton, D. G. [2 ]
Farrugia, M. E.
机构：
[1] Queen Elizabeth Univ Hosp, West Scotland Clin Genet Serv, Glasgow G51 4TF, Lanark, Scotland
[2] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland
[3] Queen Elizabeth Univ Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland
来源：
NEUROMUSCULAR DISORDERS | 2018年 / 28卷
关键词：
D O I：
10.1016/S0960-8966(18)30321-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
D18
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [31] Central Bradypnea and Ataxic Breathing in Myotonic Dystrophy Type 1-A Clinical Case Report
    Summ, Oliver
    Mathys, Christian
    Grimm, Teresa
    Gross, Martin
    JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (03) : 465 - 471
  • [32] FALLS AND FUNCTIONAL MEASURES IN ADULTONSET MYOTONIC DYSTROPHY TYPE 1: A CROSS-SECTIONAL STUDY
    Pucillo, E.
    DiBella, D.
    Pautler, M.
    Trujillo, C.
    Hung, M.
    Bounsanga, J.
    Butterfield, R.
    Johnson, N.
    MUSCLE & NERVE, 2016, 54 : 13 - 13
  • [33] Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review
    Mateus, Tiago
    Costa, Adriana
    Viegas, Diana
    Marques, Alda
    Herdeiro, Maria Teresa
    Rebelo, Sandra
    NEUROMUSCULAR DISORDERS, 2022, 32 (02) : 99 - 115
  • [34] PATIENT PREFERENCES ON THE USE OF THREE, PATIENT-REPORTED OUTCOME MEASURES OF HEALTH IN MYOTONIC DYSTROPHY TYPE 1
    Heatwole, C.
    Johnson, N.
    Dekdebrun, J.
    Dilek, N.
    Eichinger, K.
    Hilbert, J.
    Luebbe, E.
    Martens, W.
    McDermott, M.
    Thornton, C.
    Moxley, R.
    MUSCLE & NERVE, 2016, 54 : 8 - 8
  • [35] Impact Of Cancer And Chemotherapy On Autonomic Nervous System Function: A Case-controlled Feasibility Study
    Adams, Scott C.
    Schondorf, Ronald
    Benoit, Julie
    Kilgour, Robert
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2015, 47 (05): : 757 - 757
  • [36] Longitudinal progression of motor function in individuals with myotonic dystrophy type 1: insights from the END-DM1 study
    Johnson, N.
    Hung, M.
    Sansone, V.
    Subramony, S.
    Statland, J.
    Hamel, J.
    van Engelen, B.
    Mul, K.
    Elsheikh, B.
    Roxburgh, R.
    Day, J.
    Swenson, A.
    Schoser, B.
    Ragole, T.
    Greene, E.
    Shieh, P.
    Thornton, C.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [37] Sleep disorders in adult-onset myotonic dystrophy type 1: a controlled polysomnographic study
    Romigi, A.
    Izzi, F.
    Pisani, V.
    Placidi, F.
    Pisani, L. R.
    Marciani, M. G.
    Corte, F.
    Panico, M. B.
    Torelli, F.
    Uasone, E.
    Vitrani, G.
    Albanese, M.
    Massa, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 (09) : 1139 - 1145
  • [38] Myotonic Dystrophy Type-1: Patient Validation Study of the Highest-Impact Symptoms and Issues
    Heatwole, Chad
    Bode, Rita
    Johnson, Nicholas
    Quinn, Christine
    Martens, William
    Moxley, Richard
    Vickrey, Barbara
    Victorson, David
    NEUROLOGY, 2011, 76 (09) : A529 - A530
  • [39] Study design of an assessment protocol for central and peripheral fatigue in myotonic dystrophy type 1 DM1
    Baldanzi, S.
    Bottari, M.
    Simoncini, C.
    Ricci, G.
    Siciliano, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 209 - 209
  • [40] Myopathy in trunk muscles in Myotonic Dystrophy type-1: a case control study with MRI
    Solbakken, G.
    Bjornara, B.
    Kirkhus, E.
    Nguyen, B.
    Hansen, G.
    Frich, J.
    Orstavik, K.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 541 - 541
12345